In conclusion, our study not only uncovered a novel function of GALNT14 in the lung metastasis of breast cancer and delineated the underlying molecular mechanisms but also suggests that this enzyme can be a potential therapeutic target for breast cancer treatment. This evidence concerns the gene GALNT14 and breast carcinoma.